The Society of Dermatology Physician Assistants (SDPA) recognizes emerging evidence on potential adverse effects associated with prolonged topical corticosteroid use in managing chronic inflammatory dermatoses. These findings highlight the need for vigilant treatment planning to mitigate long-term risks. To prioritize patient safety and optimize outcomes, the SDPA advocates for routine assessment of cumulative steroid exposure as a cornerstone of patient care.
Redesigned. Reimagined. Ready for You.
Experience the next evolution in advanced PA education with the all-new SDPA Diplomate Program — a legacy of excellence, now completely revamped for today’s dermatology PAs.
DermPAs™ are highly trained medical professionals who work in partnership with board-certified dermatologists to expand access to timely, high-quality dermatologic care. Committed to collaboration and patient-centered care, DermPAs™ play an essential role in meeting growing healthcare demands.
We encourage SDPA members to contact Dermatology News (email the Editor-In-Chief, Mary Jo M. Dales, at mdales@frontlinemedcom.com) to provide your input on Dr. Coldiron’s ongoing derogatory attacks against our profession. Please also ask your collaborating physicians to provide their insight based on actual experience with the value PAs bring to their practice."
"Our support of FPAR reflects the need to support the evolution of PA practice as it relates to the healthcare team and protect the viability of our profession, not a desire to practice apart from the dermatologists whom we learn from at all stages of our careers and with whom we share our passion for excellence in dermatologic patient care."